IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS

Children with bronchopulmonary dysplasia belong to the risk group of severe respiratory-syncytial viral infection (RSV). World experience and authors' own clinical data show that seasonal immunoprophylaxis of RSV infection's severe course by palivizumab in these patients allows reducing frequency of...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	A. A. Baranov, I. V. Davydova, T. V. Turti, L. S. Namazova-Baranova, V. V. Altunin, E. P. Zimina, E. V. Pavlyukova
Format:	Artigo
Sprache:	Russo
Veröffentlicht:	Union of pediatricians of Russia 2012-12-01
Schriftenreihe:	Педиатрическая фармакология
Schlagworte:	respiratory-syncytial virus bronchopulmonary dysplasia acute respiratory viral infection respiratory function palivizumab
Online-Zugang:	https://www.pedpharma.ru/jour/article/view/268
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!